胃肠道恶性肿瘤患者CD4+CD25+调节性T细胞的检测及意义

被引:10
作者
吕承刚
李永翔
机构
[1] 安徽医科大学第一附属医院普外科
关键词
肿瘤; 调节性T细胞; Foxp3; 流式细胞术; 免疫组化中;
D O I
10.19405/j.cnki.issn1000-1492.2012.07.016
中图分类号
R735 [消化系肿瘤];
学科分类号
100112 [医学生物化学与分子生物学];
摘要
目的探讨胃肠道恶性肿瘤患者外周血及病理组织调节性T细胞(Tregs)的表达及临床意义。方法采用流式细胞仪对60例胃肠道恶性肿瘤患者及20例健康对照者外周血CD4+CD25+Foxp3+T细胞占CD4+T细胞(CD4+CD25+Foxp3+Tregs/CD4+T)的比率进行检测,采用免疫组化法检测相应患者病理组织中CD4+CD25+Foxp3+Tregs的表达水平。结果胃癌、结直肠癌患者外周血CD4+CD25+Foxp3+Tregs/CD4+T细胞的比率分别为(7.46±0.85)%和(7.79±1.19)%,与对照组(6.65±0.79)%比较,差异有统计学意义(P<0.01)。胃癌、结直肠癌病理组织中CD4+CD25+Foxp3+Tregs的表达平均阳性细胞绝对数为(53.52±16.31)和(58.15±14.86),与癌旁组织(6.53±2.68)比较,差异有统计学意义(P<0.01)。结论胃癌、结直肠癌患者外周血及病理组织中Tregs的高表达可能具有肿瘤免疫的抑制作用,并与肿瘤的发生、发展密切相关。
引用
收藏
页码:817 / 820
页数:4
相关论文
共 6 条
[1]
Intratumoral CD8+ T/FOXP3+ cell ratio is a predictive marker for survival in patients with colorectal cancer [J].
Suzuki, Hiroyuki ;
Chikazawa, Nobuhito ;
Tasaka, Takehiko ;
Wada, Junji ;
Yamasaki, Akio ;
Kitaura, Yoshiki ;
Sozaki, Masae ;
Tanaka, Masao ;
Onishi, Hideya ;
Morisaki, Takashi ;
Katano, Mitsuo .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (05) :653-661
[2]
Aging and human CD4+ regulatory T cells [J].
Hwang, Kyung-A. ;
Kim, Hang-Rae ;
Kang, Insoo .
MECHANISMS OF AGEING AND DEVELOPMENT, 2009, 130 (08) :509-517
[3]
Intraepithelial Effector (CD3+)/Regulatory (FoxP3+) T-Cell Ratio Predicts a Clinical Outcome of Human Colon Carcinoma [J].
Sinicrope, Frank A. ;
Rego, Rafaela L. ;
Ansell, Stephen M. ;
Knutson, Keith L. ;
Foster, Nathan R. ;
Sargent, Daniel J. .
GASTROENTEROLOGY, 2009, 137 (04) :1270-1279
[4]
Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner [J].
Yaqub, Sheraz ;
Henjum, Karen ;
Mahic, Milada ;
Jahnsen, Frode L. ;
Aandahl, Einar M. ;
Bjornbeth, Bjorn A. ;
Tasken, Kjetil .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (06) :813-821
[5]
Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration.[J].Daniela Rosenkranz;Sascha Weyer;Eva Tolosa;Alexandra Gaenslen;Daniela Berg;Thomas Leyhe;Thomas Gasser;Lars Stoltze.Journal of Neuroimmunology.2007, 1
[6]
CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers [J].
Kono, Koji ;
Kawaida, Hiromichi ;
Takahashi, Akihiro ;
Sugai, Hidemitsu ;
Mimura, Kosaku ;
Miyagawa, Naoto ;
Omata, Hideo ;
Fujii, Hideki .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2006, 55 (09) :1064-1071